[Use of G-CSF in chemotherapy of urogenital cancers].
Droz
J P
JP
Service de Médecine A, Institut Gustave Roussy, Villejuif, France.
Théodore
C
C
D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D005834:Genital Neoplasms, Male / Q000188:drug therapy*; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D009503:Neutropenia / Q000139:chemically induced / Q000188:drug therapy*; D014571:Urologic Neoplasms / Q000188:drug therapy*
D000970:Antineoplastic Agents; D016179:Granulocyte Colony-Stimulating Factor